Letko, Brosseau & Associates’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
Other funds holding SNY
BIP
Letko, Brosseau & Associates's SNY Position: Q4 2018 in Review
Letko, Brosseau & Associates sold out of Sanofi (SNY) in Q4 2018, closing a stake of 5,699 shares — an estimated $255K sold.
Letko, Brosseau & Associates first reported a position in SNY in Q2 2013 and held it in 17 quarters. The position peaked at $685K in Q1 2015. 501 funds tracked by Wall St. Rank hold SNY as of Q4 2018.
- Letko, Brosseau & Associates reported no remaining Sanofi position as of Q4 2018 after selling out during the quarter.
- Letko, Brosseau & Associates sold 5,699 Sanofi shares in Q4 2018, an estimated $255K.
- Letko, Brosseau & Associates first reported a position in Sanofi in Q2 2013 and held it in 17 quarters.
- Letko, Brosseau & Associates's Sanofi position peaked at $685K in Q1 2015.
- 501 funds tracked by Wall St. Rank held Sanofi as of Q4 2018.
Based on Letko, Brosseau & Associates's 13F filing for Q4 2018, filed 8 Feb 2019.